A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

Peer Review reports

Original Submission
28 Jan 2009	Submitted	Original manuscript
2 Mar 2009	Reviewed	Reviewer Report - Pierre Laurent-Puig
12 Mar 2009	Reviewed	Reviewer Report - Igor Jurisica
2 Apr 2009	Author responded	Author comments - Esther Black
Resubmission - Version 2
2 Apr 2009	Submitted	Manuscript version 2
26 Apr 2009	Reviewed	Reviewer Report - Pierre Laurent-Puig
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
13 May 2009	Editorially accepted
13 May 2009	Article published	10.1186/1471-2407-9-145

Back to article page